Ginkgo Bioworks Holdings (DNA) Net Income towards Common Stockholders Growth (3y) (2023 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Net Income towards Common Stockholders Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.38 Bn | 40.30 Bn | 1.44 Bn | -6.41% |
| 2 | Medpace Holdings | 16.51 Bn | 16.01 Bn | 201.64 Mn | 25.73% |
| 3 | Charles River Laboratories International | 13.16 Bn | 12.97 Bn | 452.07 Mn | -26.16% |
| 4 | Icon | 12.39 Bn | 11.46 Bn | 479.29 Mn | -7.33% |
| 5 | Fortrea Holdings | 1.57 Bn | 1.40 Bn | 139.20 Mn | -34.42% |
| 6 | Evotec SE | 621.88 Mn | 196.00 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 419.14 Mn | 334.60 Mn | 18.44 Mn | 35.41% |
| 8 | Champions Oncology | 71.79 Mn | 71.79 Mn | 7.03 Mn | 36.14% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 24.60% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.41% |
| Mar 31, 2026 | 26.14% |
| Dec 31, 2025 | 22.44% |
| Sep 30, 2025 | 50.61% |
| Jun 30, 2025 | 55.20% |
| Mar 31, 2025 | 46.40% |
| Dec 31, 2024 | 59.38% |
| Sep 30, 2024 | 18.03% |
| Jun 30, 2024 | -58.58% |
| Mar 31, 2024 | -30.43% |
| Dec 31, 2023 | -65.86% |
| Sep 30, 2023 | -126.33% |